NCT00145314 FLOX in Combination With Cetuximab in First-line Treatment of Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00138060 Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants Status COMPLETED Phase PHASE4